first glp 1 approval GLP-1 PILL: The FDA just approved the first ever GLP-1 pill for weight loss, according to a Novo Nordisk, the makers of Wegovy. Link in bio for the details GLP-1R Agonists for Weight Loss

Well see what the details are if it passes

Limited clinical trial data to justify its use in COVID-19 Most of the clinical studies where NAC has been used (either alone or in combination with another drug) tend to focus on its use as a mucolytic in two population subgroups: paediatric populations at lower doses where its antioxidant effects are less evident (6) with studies dating mainly from the 1970s and 1980s of low quality evidence

Aunque la pancreatitis asociada con agonistas GLP-1 es rara, es una complicacin potencialmente grave que requiere discontinuacin inmediata del medicamento y manejo hospitalario

Przykadowo ChPL produktu z semaglutydem stosowanego w kontroli masy ciaa wskazuje stosowanie wraz z diet o obnionej wartoci kalorycznej i zwikszonym wysikiem fizycznym u dorosych z BMI 30 kg/m lub z BMI 27 kg/m i co najmniej jednym schorzeniem zwizanym z nieprawidow mas ciaa, takim jak zaburzenia gospodarki wglowodanowej, nadcinienie ttnicze, dyslipidemia, obturacyjny bezdech senny albo choroba sercowo-naczyniowa

They may also be necessary when certain medications interfere with B12 absorption or in any other diagnosed condition specifically impacting B12 uptake